January 19 @ 12:00 pm - 1:00 pmFree
- This event has passed.
About this event
The Center for Experimental Therapeutics at the OHSU Knight Cancer Institute is working to develop better treatments for cancer patients through collaboration within OHSU and with other academic centers, biotech and pharma companies around the world.
The center unites cutting-edge technologies with a multidisciplinary group of clinicians and scientists to advance drug discovery and development. OHSU is one of the few universities nationally, to bring together the infrastructure to translate scientific discoveries from the lab into effective therapies for human diseases.
The center focuses on drug development and discovery from preclinical phases to clinical and translational research.
Learn more about The Center for Experimental Therapeutics at this OBI Lunch & Learn.
About the Speaker:
Sanjay V. Malhotra, PhD, FRSC
Dr. Malhotra is a Professor & Endowed Chair in Cancer Research in the Department of Cell Development and Cancer Biology and also Director, Center for Experimental Therapeutics at the Knight Cancer Institute, OHSU.
Before joining OHSU in July 2020, he was a faculty member in the departments of Radiation Oncology (Cancer and Radiation Biology), Radiology (Molecular Imaging Program) and Medicine, at the Stanford University School of Medicine. Dr. Malhotra also served as the Director, Stanford-SRI Drug Discovery and Development Program of the Stanford Cancer Institute. Previously, Dr. Malhotra was ‘Principal Investigator and Head’ of the ‘Small Molecule Drug Discovery Laboratory’ at the National Cancer Institute (NCI), NIH, and served as the Director, Chemical Diversity Division of the Chemical Biology Consortium/NCI.
He has over 20 years of experience in basic and translational research. His interests focus on the design and discovery of synthetic and natural product inspired small molecules as probes to understand biological phenomena, and translational research in drug discovery, development, imaging and radiation. Dr. Malhotra’s work has led to preclinical and clinical advancement of several molecules. He has edited five books and authored over 150 research articles. Dr. Malhotra is a Fulbright Specialist and Fellow of the Royal Society of Chemistry, UK.